baber/WOPTO huggingface dataset:
Patent IE-830135-L (IE)
Title: Cyclohexane diones
IPC: C07C255/56
Filed: 1983-01-24
Abstract: The invention concerns novel compounds of the formula I <IMAGE> I wherein: X is selected from halogen, nitro, cyano, alkyl, substituted alkyl, hydroxy, alkoxy, substituted alkoxy, alkenyl, alkynyl, alkenyloxy, alkynyloxy, acyloxy, alkoxycarbonyl, alkylthio, alkylsulfinyl, alkylsulfonyl, sulfamoyl, substituted sulfamoyl, amino, substituted amino, and the groups formyl and alkanoyl and the oxime, imine and Schiff base derivatives thereof; R1 is selected from hydrogen, alkyl, alkenyl, alkynyl, substituted alkyl, alkylsulfonyl, arylsulfonyl, acyl and an inorganic or organic cation; R2 is selected from alkyl, substituted alkyl, alkenyl, haloalkenyl, alkynyl and haloalkynyl; R3 is selected from alkyl, fluoroalkyl, alkenyl, alkynyl, and phenyl; m is an integer chosen from 3 to 5. The compounds of the invention show herbicidal properties and plant growth regulating properties and in further embodiments the invention provides processes for the preparation of compounds of formula I, intermediates useful in the preparation of the compounds of formula I, compositions containing as active ingredient a compound of formula I, and herbicidal and plant growth regulating processes utilizing compounds of formula I.
[US4666510A]
Patent IE-800137-L (IE)
Title: Column line powered static ram cell
IPC: H01L23/522
Filed: 1980-01-24
Abstract: In a static RAM comprising cross coupled FETs Q1, Q2 one of the power supply lines is eliminated by connecting the load elements R1, R2 to the data lines. Both load elements may be connected to the same data line D as shown or alternatively to data line D or each resistor may be separately connected to one or other of the data lines D, D. The load elements have a high value which together with the capacitance at the data nodes 1 and 2 provides a long time constant and when writing into a cell the appropriate data line is pushed for period shorter than the time constant of the load circuits so that cells connected to the same data line are not affected unless the row address line RA is energised. <IMAGE>
[GB2068167A]
Patent IE-870332-L (IE)
Title: Slow release formulation.
IPC: A61K9/22
Filed: 1987-02-09
Abstract: A slow release formulation to be administered to humans or animals, comprising primary granules (1) which contain an active ingredient and are in a secondary matrix (2) of a water soluble/ dispersible slow release material, the granules (1) themselves comprising particles (3) containing the active ingredients and in a primary matrix (4) of a water soluble/dispersible slow release material.Optionally the formulation comprises a binder phase (5) of a water insoluble slow release material having embedded therein secondary granules (6) comprising the secondary matrix (2) containing the primary matrix granules (1).The water soluble/dispersible material may be a polysaccharide and acacia and low viscosity methylcellulose are exemplified, as well as alginate and gelatine.
Patent IE-38935-L (IE)
Title: Hair driers
IPC: A45D1/00
Filed: 1974-02-27
Abstract: A hand held hair drying appliance particularly useful in the styling or shaping of hair including a tubular housing having two spaced inlets, an outlet disposed between the two inlets and a tubular handle portion formed by said housing; a heating element disposed in the housing between the inlets; first and second fans arranged in the housing to force air from the inlets toward the outlet; the first and second fans each having blades extending radially from the axis of rotation, the blades of the first fan having a pitch opposite the pitch of the blades of the second fan such that the first and second fans form oppositely directed currents of air when rotated in the same direction; and a motor disposed in the handle for driving the fans whereby air is drawn into the housing through the inlets, moved past the heating element and expelled through the outlet in a direction transverse to the axis of the housing for drying hair.
[US3885127A]
Patent IE-36233-L (IE)
Title: Milk replacer
IPC: A23C11/04
Filed: 1972-03-28
Abstract: 1318848 Milk replacer AKZO NV 27 March 1972 [26 April 1971] 14273/72 Heading A2B A mother's milk replacer for non-human mammals, in particular calves, comprises fats, proteins, carbohydrates, and minerals, the protein content including at least one source of protein other than skim milk, there being present sufficient calcium disodium ethylene diamine tetra-acetate such that the assimilable iron content does not exceed 10 ppm. 
The protein may be for example soya powder, fish meal, blood meal, whey powder, potato protein or protein obtained by growing yeast cells on a paraffin wax nutrient medium. 
(From GB1318848 A) 
[FR2134481A1]
Patent IE-900537-L (IE)
Title: Anesthetic oral compositions
IPC: A61K31/445
Filed: 1990-02-14
Abstract: Disclosed are oral anesthetic pharmaceutical compositions comprising: (a) from about 0.02% to about 25% of a pharmaceutically acceptable acid salt of a beta -aminopropiophenone, such as dyclonine HCl; (b) from about 0.02% to about 20% of saccharin; and (c) from about 1% to about 99% of a pharmaceutically acceptable oral carrier. Also provided are methods for providing an anesthetic effect in humans or animals which comprises orally administering to said human or animal a safe and effective amount of these pharmaceutical compositions. Also provided is a novel process for the manufacture of anesthetic lozenges containing a beta -aminopropiophenone along with saccharin.
[EP0383481A2]
Patent IE-43219-L (IE)
Title: Mouldable polyimide compositions
IPC: C08L79/08
Filed: 1976-03-19
Abstract: A shaped article is disclosed consisting essentially of a matrix of thermoplastic polymer in which there is dispersed, in the form of particles of mean diameter less than 200 mu , a polyimide resin comprising the reaction product of (a) a bis-imide of the formula: <IMAGE> (I) and (b) a diamine of the formula:
[US4144284A]
Patent IE-790626-L (IE)
Title: Extraction of aluminium values from coal ash
IPC: C01F7/66
Filed: 1979-08-08
Abstract: The combustion residue or ash, obtd. from burning a solid fuel contg. carbon, contains by wt. max. 4% Fe calculated as Fe2O3, and max. 2% carbon. The ash is treated by the steps: (a) pretreating with excess HNO3 at a temp. (Ta) and removing the HNO3 soln. (a1) thus obtd. (b) the residue from step (a) is leached with excess HNO3 of 30-65 wt.% strength at Tb = 100-225 degrees C., where Tb is higher than Ta. When the ash is obtd. by fluidised bed combustion, step (a) pref. uses 30-65% HNO3 for 1-5 hr. at 40-90 degrees C., whereas step (b) is at 100-130 degrees C. When the ash is obtd. from burning powdered coal, step (a) pref. uses 30-65% HNO3 for 1-5 h. at 100-120 degrees C., whereas step (b) is at 150-225 degrees C. The ash is pref. first heated in air to reduce the carbon to max. 2%; and magnetic sepn. is pref. used to reduce the iron to max. 2% Fe2O3. Many lands contain little or no bauxite, and the latter continues to rise in cost. The invention provides for winning Al, e.g. as Al2O3 with high purity.
[FR2419330A1]
Patent IE-890641-L (IE)
Title: 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
IPC: C07D279/04
Filed: 1989-02-28
Abstract: 5-Lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols having the formula <CHEM> wherein R<1> and R<2> each independently are hydrogen, C1-6alkyl or halo; R<3> and R<4> each independently are hydrogen, halo, amino, nitro or trifluoromethyl; Y is a heterocyclic radical of formula <CHEM> for use as a medicine. Compositions containing these compounds as active ingredient. Novel 4-(4-phenyhl-1-piperazinyl)phenols and methods for preparing these and the aforementioned compositions.
Patent IE-790745-L (IE)
Title: Closure device
IPC: A44B19/16
Filed: 1979-08-08
Abstract: A closure fastening device comprises a first channel element including hook portions facing away from each other and a second channel element including hook portions facing towards each other, whereby the channel elements interlock by pressing the first channel element into the second channel element so that the hook portions engage each other at predetermined contact surfaces. The closure fastening device can be connected to the opening of a container to form a container capable of being closed and opened.
[US4212337A]
Patent IE-33997-L (IE)
Title: Cephalosporin derivatives
IPC: A61K31/545
Filed: 1969-06-13
Abstract: 1279402 Cephalosporanic acids GLAXO LABORATORIES Ltd 30 May 1969 [14 June 1968] 28528/68 Heading C2A Novel cephalosporanic acids having the Formula I: and salts, esters or anhydrides thereof, wherein Y is -CH 2 - or -CO- and R is bromo, azido or an aliphatic, carbocyclic aromatic, heterocyclic aromatic having 1 or 2 hetero atoms, araliphatic or cycloaliphatic group, and the group RYCO has an atomic weight sum of at least 120 when R is a carbocyclic aromatic group, m is 0 or 1, and R<SP>2</SP> is hydrogen or,C 1 -C 3 alkyl which may be substituted by carboxy, carboalkoxy or mercapto, provided that when m is 0 and R<SP>2</SP> is methyl the group Y is -CO-, are prepared by (a) acylating a correspondingly 3-substituted 7-aminocephalosporanic acid or acid-addition or base salt or easily hydrolysable ester thereof with an acylating agent corresponding to the acid RYCOOH, or (b) reacting a correspondingly N - acylated cephalosporanic acid, salt or ester having a group -CH 2 P at the 3-position, P being a group replaceable by the group -S(O) m R<SP>2</SP>, with a thioetherifying agent corresponding to the latter group and, if desired, in (a) or (b) subsequently oxidizing a 3-CH 2 SR<SP>2</SP> group to a 3-CH 2 SOR<SP>2</SP> group. Suitable acylating agents are the acid halide, anhydride or mixed anhydride, an active ester or azide of the acid, or the acid itself together with a condensing agent. The group P may be an acetoxy group, in which case the thioetherifying agent is an appropriate thiol. Alternatively the starting material may be a 3-hydroxymethyl compound which is first converted to a compound having a group -CH 2 X at position 3, X being a group (e.g. halogen) such that the acid HX has a pKa of not more than 4À0 in water at 25‹ C., and then the 3-CH 2 X compound is reacted with a thiol so that the thiol residue replaces X by nucleophilic displacement. A catalyst, e.g. a salt of Hg, Ag or Au, is often helpful in this replacement reaction. The sulphinyl compounds (i.e. wherein m is 1) may be prepared by nucleophilic displacement as described above, using a sulphenic acid R<SP>2</SP>SOH in place of the thiol, or by oxidation of the 3-thio-ether, e.g. with chromic oxide, sodium periodate, dibenzoyl peroxide, peracetic acid, or oxygen in a tetrahydrofuran medium containing peroxide. Pharmaceutical compositions having antibiotic activity against gram-positive and -negative bacteria comprise a cephalosporanic acid of Formula I as defined above except that the proviso need not apply, or a non-toxic salt or ester thereof, together with a pharmaceutical carrier or excipient. The compositions may be in oral, topical or injectable forms or in the form of an intra-mammary preparation for veterinary use. Reference has been directed by the Comptroller to Specification 1,104,937.
[GB1279402A]
Patent IE-37155-L (IE)
Title: Tyres, moulding tread form
IPC: B29D30/54
Filed: 1972-07-10
Abstract: 1399864 Moulding tyres DUNLOP Ltd 10 July 1972 [21 July 1971] 34113/71 Heading B5A A tread for subsequent application to a pneumatic tyre is moulded from an annular slug 16 of rubber placed between mould parts 10, 11 which are brought together under a pressure of 1500- 2000 p.s.i. to force the rubber into a mould cavity formed between the parts: 10, 11 and a segmental annular core 18 which holds a breaker assembly 5. The partially cured tread is applied to an unvulcanized tyre carcass and the assembly completely vulcanized. Alternatively the tread is stitched to a buffed worn tyre casing to which additional partially cured rubber for the sidewalls is stitched and vulcanization then effected.
[GB1399864A]
Patent FI-803929-L (FI)
Inventor: SIEGERS GUENTER
IPC: B01D15/00
Filed: 1980-12-16
Abstract: An apparatus for the countercurrent treatment of liquids with adsorbents in an adsorption-filter the space of which is divided by trays which are permeable to liquids into at least 2 chambers, in which before and/or during the charging of the adsorbent in the upward flow, the regeneration of the charged adsorbent in the downward flow and the backwasting in the upward flow particular levels to which the industrial chambers are filled are established by transferring adsorbent from one chamber to the adjacent chamber.
Patent FI-822500-L (FI)
Inventor: BARTELLONI RENE
IPC: E04C2/16
Filed: 1982-07-13
Abstract: 1. Flexible natural-shade or coloured products for construction, facing, insulating or packaging, comprising papermaking sludges, a resin and mineral or organic fillers, characterized in that they comprise : - papermaking sludges from settling tanks in a proportion of between 10 and 92 %, - latex (natural or synthetic) in a proportion of between 3 and 75 %, - a cross-linking agent in the form of a condensate of diamide and formaldehyde of low molecular weight and - mineral organic fillers in a proportion of between 5 and 70 %.
Patent FI-851870-L (FI)
Inventor: GEYER ARTHUR
IPC: C03B37/018
Filed: 1985-05-10
Abstract: A method and apparatus for producing a directed aerosol stream from gaseous and/or vapor phase reactants by conveying the reactants to a reaction site, reacting the reactants at the reaction site in a flame free chemical reaction to produce an aerosol composition, and causing the aerosol composition to flow from the reaction site and immediately surrounding the aerosol composition with a moving, essentially aerosol free gas and/or vapor stream to form a directed aerosol stream enveloped in the aerosol free stream, in which the step of conveying includes conducting each reactant through a respective distributor and then through a discharge element having a substantially higher flow resistance than the distributor in a substantially vertical upward direction to the reaction site, and the step of causing is carried out so that the aerosol composition flows in a substantially vertical upward direction.
Patent IE-841177-L (IE)
Title: Silent film for ostomy pouches
IPC: C08L31/04
Filed: 1984-05-11
Abstract: This invention relates to films which have a high degree of silence and pliability and comprise at least one layer formed from a polymeric blend which includes about 40% to 60% by weight of any ethylene and vinyl-acetate copolymer and about 60% to 40% by weight of an elastomeric polyolefin. The elastomeric polyolefin preferably comprises a blend or "alloy" of an ethylene and vinyl-acetate copolymer and an elastomeric ethylene and propylene copolymer. Such films are particularly useful for manufacturing drainage containers or bags for medical applications.
[US4687711A]
Patent IE-33557-L (IE)
Title: Penicillins and cephalosporins
IPC: C07D501/20
Filed: 1969-09-10
Abstract: Penicillin and cephalosporim derivs. M3A. Compds. (I) and (II) are of formula: (Where R' is an amide residue for a known natura or synthetic penicillin or cephalosposin, haloimide or alkoxy-imido derivs. of such an amide residue or amino. R18 is Me, HOCH2, N-pyridinium methyl or alkanocyl-methyl X is an electrophilic group, Y is an electrophilic group or a non-electrophilic group or X and Y together form a cyclic electrophilic group esp. a group: (where R16 and R17 are H, halogen, alkyl, alkoxy, phenyl phenylalkyl, alkoxyphenyl, aryl, heterocyclyl, CF3, NO2 dialkylamino, sulphonamido, carbalkoxy, CN, alkylthio, alkylsulphonyl or together with the benzene ring form a naphthyl residue). They are prepd. by reacting a penicillin or caphalosporin or a carboxylic acid deriv. thereof with an amine to form the 2-amide, then opt. reacting this with PCl5 and a base to form. (I) or (II) R' = haloimide residue, then with an alkanol to form (I) or (II) R' =alkoxy imido residue, hydrolysing to give (I) or (II) R' = NH2 and opt. acylating to give (I) or (II) R' = acylamino (different from the starting acylamino residue. (I) or (II) R' = acylamino (different from the starting acylamino residue). The process may be extended to include the hydrolysis of (I) or (II) to give the parent penicillin or sephalasporin.
[FR2018219A1]
Patent IE-33320-L (IE)
Title: Voltage controllabe capacitor
IPC: H01L29/00
Filed: 1969-09-16
Abstract: 1283383 Semi-conductor devices GENERAL ELECTRIC CO 26 Sept 1969 [10 Oct 1968] 47576/69 Heading H1K The capacitance associated with PN-junction 20, 24 is greatly increased by the formation of an inversion region of controllable extent under capacitative electrode 17, 15A. Electrode layer 17 (with terminals 11/33 and 12/34) is resistive so that an increasing control potential applied to the electrode (12) nearest the PN junction leads to the formation of an inversion layer extending increasingly from the junction. A less-thaninverting voltage obtained from potentiometer 31 at the other end of this layer determines the value of the voltage at the junction end of the electrode at which inversion first occurs. That part only of electrode 17 is effective which lies on the thinner part 15A of the insulation 15. The shape of the control voltage-capacitance characteristic may therefore be tailored by suitably shaping the thinner area of insulation or by providing a shaped electrode 17 on part only of the thinner area (see Figs. 10 and 11, not shown). In embodiments the semi-conductor body is of silicon; the insulator layer 15, 15A is of silicon dioxide; the terminals 11, 12 are of molybdenum; the resistive layer 17 is of chromium nitride or of amorphous silicon; protective insulation 21 for the resistive layer is of silicon nitride; overlying insulation 18 is of phosphosilicate or borosilicate glass if the diffused zone 20 is formed near the end of the manufacture or is of undoped material if the junction is formed near the beginning of the manufacture; and terminal layers 25, (26), and 27 are of aluminium. The capacitor may be an individual device or may form part of an integrated circuit such as one containing IGFETs formed during common processing steps.
[GB1283383A]
Patent IE-37072-L (IE)
Title: 2,4-diamino-5-benzylpyrimidines
IPC: C07D239/48
Filed: 1972-10-10
Abstract: 1413471 2,4-Diamino-5-benzyl pyrimidines WELLCOME FOUNDATION Ltd 12 Oct 1972 [12 Oct 1971 10 Dec 1971] 47492/71 and 57512/71 Heading C2C Compounds having the general formula wherein one of Q<SP>1</SP> and Q<SP>2</SP> is a 2,4-diaminopyrimidin.5-yl methyl group, R<SP>1</SP>, R<SP>2</SP>, R<SP>3</SP> and the other Q group are hydrogen, halogen or C 1 to C 4 alkyl or alkoxy, and R<SP>6</SP> is hydrogen or alkyl, provided that when Q<SP>2</SP> is the pyrimidyl group Q<SP>1</SP> is not hydrogen; may be prepared by reacting a compound of formula wherein R<SP>71</SP> is hydroxyl, halogen, or the anionic residue of a carboxylic or sulphonic acid, with a compound of the formula wherein at least one of R<SP>4</SP> and R<SP>5</SP> is hydrogen and the other is hydrogen, halogen or C 1 to C 4 alkyl or alkoxy, in a polar non-phenolic solvent capable of dissolving both reactants, and, when R<SP>6</SP> is alkyl, alkylating the product with an alkylating agent R<SP>6</SP>Z wherein Z is a reactive atom or group. The invention further comprises compounds having the general formula wherein whenever Q<SP>1</SP> is 2,4-diaminopyrimidin- 5-yl-methyl and whenever at least one of R<SP>3</SP> and Q<SP>2</SP> is alkyl or alkoxy, then at least one of R<SP>1</SP> and R<SP>2</SP> is other than hydrogen.
[GB1413471A]
Patent IE-821591-L (IE)
Title: Stilbene compounds
IPC: A61K39/385
Filed: 1982-06-30
Abstract: Novel radioactive stilbene derivatives marked with iodine 125 or 131 of the formula <IMAGE> I wherein each A and B are both hydrogen or together form a double bond and R is the remainder of amino acid of the formula R-NH2 or a derivative thereof possessing an iodine acceptor group and marked with iodine 125 or 131 and their preparation and antigens obtained therefrom and a process for preparing said antigens.
[US4529713A]
Patent IE-831799-L (IE)
Title: Controlled release naproxen and naproxen sodium tablets.
IPC: A61K9/22
Filed: 1983-07-29
Abstract: A controlled release tablet for once-daily oral administration of about 500-1200 mg of naproxen or naproxen sodium, said tablet being a homogeneous matrix comprising about 4-9 weight percent of hydroxypropylmethylcellulose having a number average molecular weight in the range of from about 80,000 to about 130,000, about 81-96 weight percent naproxen or naproxen sodium, 0.1 to about 2 weight percent of a pharmacetucailly acceptable lubricating agent, and 0 to about 8 weight percent of other pharmaceutically acceptable excipients.
[US4571333A]
Patent IE-40085-L (IE)
Title: Cable spacer
IPC: H02G7/12
Filed: 1974-10-22
Abstract: 1482083 Cable spacer BRUSH SWITCHGEAR Ltd 22 Oct 1974 [27 Oct 1973] 50120/73 Heading H2C A cable spacer for use between pairs of subconductors in overhead transmission lines has two almost identical arms 1, 2 with pivoting means 6 holding them together. Each arm, at each end, has a semicircular groove 3, 4, with a resilient lining 5, to engage the cables 7, 8 and a locking means to hold the arms together. Preferably the arms are of aluminium and the lining rubber. The lining may be held in place by a projection 22 and axial movement may be prevented by circumferential grooves 23. To prevent overtightening on to the cables, projections 13 are provided and stops 20, 21 limit the amount that the arms open. Locking means may be by a captive bolt 11 in one arm 2 engaging threaded portion 10 of the other, or (not shown) clips or collars to avoid threading operation. The pivoting means 6 may be a hinge pin 14 in bores 15, 16 or by a projection 17 (Fig. 3, not shown) on each arm, forming a minor segment of a circle, engaging a hole (18, not shown) on the other arm, forming a major segment of the same circle.
[GB1482083A]
Patent IE-862227-L (IE)
Title: Pyridine derivatives.
IPC: A61K31/54
Filed: 1986-08-20
Abstract: Compounds are described of the formula: <IMAGE> (I) and physiologically acceptable salts thereof, in which R1-R7 are defined hereinafter. The compounds represented by formula (I) reduce intracellular calcium ion concentration by limiting transmembranal calcium ion concentration and thus may be useful for the treatment of cardiovascular disorders such as hypertension.
[US5162345A]
Patent IE-42844-L (IE)
Title: Process for preparing a proteolytic enzyme.
IPC: C12N9/54
Filed: 1975-11-18
Abstract: A novel enzyme having a high proteolytic activity in alkaline media and being suitable for inclusion in washing compositions and which is produced by a novel Bacillus strain designated "PB 92", or its proteolytic enzyme producing mutants or variants. A culture of the Bacillus is deposited with the Laboratory for Microbiology of the Technical University of Delft, The Netherlands, where it has been given number OR-60.
[US4002572A]
Patent IE-812690-L (IE)
Title: Precipitating whey protein.
IPC: A23J1/20
Filed: 1981-11-17
Abstract: Proteins lacking isoelectric points are precipitated out of solution by combining with the solution a protein (i.e. one or more proteins) having an isoelectric point, alkalizing the mixture to a pH of about 9-11, acidifying the mixture to a pH of about 2-4, and adjusting the pH of the mixture to the isoelectric point of the protein to precipitate novel protein complexes. A novel protein-free, undenatured dairy whey valuable for lactose crystallization and alcohol production is also obtainable.
[US4376072A]
Patent NO-792180-L (NO)
Inventor: BESTMANN HANS JUERGEN
IPC: A01N37/02
Filed: 1979-06-28
Abstract: 1. A method of attracting and combatting Panolis flammea by applying (Z)9-tetradecenyl acetate and/or (Z)9, (E)12-tetradecadienyl acetate.